2月25日 - ** 医疗设备制造商Tandem Diabetes Care TNDM.O股价上涨3.5%至33.8美元
** 公司称美国 FDA 已批准 (link) 其用于 2 型糖尿病患者的自动胰岛素输送设备 Control-IQ+
** 该设备已获得 FDA 批准，可用于 1 型糖尿病患者
** TNDM 预计该设备将于今年 3 月向美国的新老客户提供
** 股价在过去 12 个月中上涨了 13.1
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.